Biotechnology
Compare Stocks
2 / 10Stock Comparison
PMVP vs RAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Renewable Utilities
PMVP vs RAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Renewable Utilities |
| Market Cap | $77M | $4M |
| Revenue (TTM) | $0.00 | $0.00 |
| Net Income (TTM) | $-83M | $-6M |
| Total Debt | $1M | $4M |
| Cash & Equiv. | $41M | $33K |
PMVP vs RAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 25 | May 26 | Return |
|---|---|---|---|
| PMV Pharmaceuticals… (PMVP) | 100 | 102.1 | +2.1% |
| Rain Enhancement Te… (RAIN) | 100 | 50.3 | -49.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PMVP vs RAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PMVP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.76
- EPS growth 21.0%
- Lower volatility, beta 0.76, Low D/E 0.7%, current ratio 12.22x
RAIN is the clearest fit if your priority is long-term compounding.
- -74.2% 10Y total return vs PMVP's -96.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -65.1% revenue growth vs RAIN's -121.2% | |
| Quality / Margins | 5.6% margin vs RAIN's -2.4% | |
| Stability / Safety | Beta 0.76 vs RAIN's 1.20 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +66.7% vs RAIN's -62.5% | |
| Efficiency (ROA) | -51.0% ROA vs RAIN's -298.9% |
PMVP vs RAIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
PMVP and RAIN operate at a comparable scale, with $0 and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $0 |
| EBITDAEarnings before interest/tax | -$92M | -$5M |
| Net IncomeAfter-tax profit | -$83M | -$6M |
| Free Cash FlowCash after capex | -$73M | -$4M |
| Gross MarginGross profit ÷ Revenue | — | — |
| Operating MarginEBIT ÷ Revenue | — | — |
| Net MarginNet income ÷ Revenue | — | — |
| FCF MarginFCF ÷ Revenue | — | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -8.1% | — |
Valuation Metrics
PMVP leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $77M | $4M |
| Enterprise ValueMkt cap + debt − cash | $37M | $7M |
| Trailing P/EPrice ÷ TTM EPS | -1.27x | -0.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | — |
| Price / BookPrice ÷ Book value/share | 0.42x | — |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
PMVP leads this category, winning 3 of 4 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), RAIN scores 3/9 vs PMVP's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -55.3% | — |
| ROA (TTM)Return on assets | -51.0% | -3.0% |
| ROICReturn on invested capital | -38.0% | — |
| ROCEReturn on capital employed | -41.2% | — |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.01x | — |
| Net DebtTotal debt minus cash | -$40M | $3M |
| Cash & Equiv.Liquid assets | $41M | $32,604 |
| Total DebtShort + long-term debt | $1M | $4M |
| Interest CoverageEBIT ÷ Interest expense | — | -148.90x |
Total Returns (Dividends Reinvested)
PMVP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RAIN five years ago would be worth $2,575 today (with dividends reinvested), compared to $413 for PMVP. Over the past 12 months, PMVP leads with a +66.7% total return vs RAIN's -62.5%. The 3-year compound annual growth rate (CAGR) favors PMVP at -33.8% vs RAIN's -36.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +17.9% | -62.4% |
| 1-Year ReturnPast 12 months | +66.7% | -62.5% |
| 3-Year ReturnCumulative with dividends | -70.9% | -74.2% |
| 5-Year ReturnCumulative with dividends | -95.9% | -74.2% |
| 10-Year ReturnCumulative with dividends | -96.1% | -74.2% |
| CAGR (3Y)Annualised 3-year return | -33.8% | -36.4% |
Risk & Volatility
PMVP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PMVP is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than RAIN's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PMVP currently trades 77.1% from its 52-week high vs RAIN's 19.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.20x |
| 52-Week HighHighest price in past year | $1.88 | $9.58 |
| 52-Week LowLowest price in past year | $0.81 | $1.80 |
| % of 52W HighCurrent price vs 52-week peak | +77.1% | +19.6% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 36.6 |
| Avg Volume (50D)Average daily shares traded | 727K | 18K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
PMVP leads in 4 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency.
PMVP vs RAIN: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — PMVP or RAIN?
Over the past 5 years, Rain Enhancement Technologies Holdco Inc (RAIN) delivered a total return of -74.
2%, compared to -95. 9% for PMV Pharmaceuticals, Inc. (PMVP). Over 10 years, the gap is even starker: RAIN returned -74. 2% versus PMVP's -96. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — PMVP or RAIN?
By beta (market sensitivity over 5 years), PMV Pharmaceuticals, Inc.
(PMVP) is the lower-risk stock at 0. 76β versus Rain Enhancement Technologies Holdco Inc's 1. 20β — meaning RAIN is approximately 58% more volatile than PMVP relative to the S&P 500.
03Which is growing faster — PMVP or RAIN?
On earnings-per-share growth, the picture is similar: PMV Pharmaceuticals, Inc.
grew EPS 21. 0% year-over-year, compared to -34. 9% for Rain Enhancement Technologies Holdco Inc. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — PMVP or RAIN?
PMV Pharmaceuticals, Inc.
(PMVP) is the more profitable company, earning 0. 0% net margin versus 0. 0% for Rain Enhancement Technologies Holdco Inc — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PMVP leads at 0. 0% versus 0. 0% for RAIN. At the gross margin level — before operating expenses — PMVP leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — PMVP or RAIN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is PMVP or RAIN better for a retirement portfolio?
For long-horizon retirement investors, PMV Pharmaceuticals, Inc.
(PMVP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76)). Both have compounded well over 10 years (PMVP: -96. 1%, RAIN: -74. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between PMVP and RAIN?
These companies operate in different sectors (PMVP (Healthcare) and RAIN (Utilities)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.